Anti‐Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans
暂无分享,去创建一个
A. Schoepfer | F. Seibold | S. Müller | B. Flogerzi | B. Seibold-Schmid | T. Schaffer | B. Seibold‐Schmid
[1] D. Poulain,et al. Comparative analysis of cell wall surface glycan expression in Candida albicans and Saccharomyces cerevisiae yeasts by flow cytometry. , 2006, Journal of immunological methods.
[2] J. Mallet,et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. , 2006, Gastroenterology.
[3] F. Seibold,et al. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis. , 2005, World journal of gastroenterology.
[4] M. Aigle,et al. Molecular genetic study of introgression between Saccharomyces bayanus and S. cerevisiae , 2005, Yeast.
[5] R. Balicer,et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.
[6] J. Belisle,et al. Export-Mediated Assembly of Mycobacterial Glycoproteins Parallels Eukaryotic Pathways , 2005, Science.
[7] K. Takegawa,et al. Characterization of O-mannosyltransferase family in Schizosaccharomyces pombe. , 2005, Biochemical and biophysical research communications.
[8] F. Seibold,et al. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. , 2004, Gastroenterology.
[9] D. Jewell,et al. The contribution of HLA genes to IBD susceptibility and phenotype. , 2004, Best practice & research. Clinical gastroenterology.
[10] F. Seibold,et al. Immune Sensitization to Yeast Antigens in ASCA-positive Patients with Crohn’s Disease , 2004, Inflammatory bowel diseases.
[11] T. Kozel,et al. Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan , 2004, Infection and Immunity.
[12] G. Mitterdorfer,et al. Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques , 2002, Journal of applied microbiology.
[13] A. Otter,et al. The Unique Solution Structure and Immunochemistry of theCandida albicans β-1,2-Mannopyranan Cell Wall Antigens* 210 , 2002, The Journal of Biological Chemistry.
[14] M. Scheurlen,et al. Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family Study , 2001, Scandinavian journal of gastroenterology.
[15] D. McClish,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] M. Gentzsch,et al. Protein O-mannosylation. , 1999, Biochimica et biophysica acta.
[17] J. Mccusker,et al. Species Identification and Virulence Attributes ofSaccharomyces boulardii (nom. inval.) , 1998, Journal of Clinical Microbiology.
[18] K. Ziegelbauer,et al. Multiple Functions of Pmt1p-mediated ProteinO-Mannosylation in the Fungal Pathogen Candida albicans * , 1998, The Journal of Biological Chemistry.
[19] L. Kasper,et al. Some Opportunistic Parasitic Infections in AIDS: Candidiasis, Pneumocystosis, Cryptosporidiosis, Toxoplasmosis. , 1998, Parasitology today.
[20] S. Suzuki. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. , 1997, Current topics in medical mycology.
[21] S. Suzuki,et al. Amended structure of side chains in a cell wall mannan from Candida albicans serotype A strain grown in yeast extract-Sabouraud liquid medium under acidic conditions: detection of the branched side chains corresponding to antigenic factor 4. , 1997, FEMS microbiology letters.
[22] D. M. Lupan,et al. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans , 1996, Infection and immunity.
[23] P. Jacquinot,et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.
[24] S. Misbah,et al. A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency. , 1992, Journal of immunological methods.
[25] J. Main,et al. Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease. , 1992, FEMS microbiology immunology.
[26] M. Sogin,et al. Evolutionary relationships among pathogenic Candida species and relatives , 1991, Journal of bacteriology.
[27] M. Kerr,et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.
[28] J. Jones. Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans , 1980, Infection and immunity.
[29] E. Reiss,et al. Comparison by Elisa of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients , 1980, Mycopathologia.
[30] T. Nakase,et al. Serologic aspects on yeast classification , 1974, Mycopathologia et mycologia applicata.
[31] C. Ballou,et al. Method for Fingerprinting Yeast Cell Wall Mannans , 1969, Journal of Bacteriology.